Gabriella Spengler

Author PubWeight™ 20.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biological activity of persimmon (Diospyros kaki) peel extracts. Phytother Res 2003 1.49
2 Biological activity of barbados cherry (acerola fruits, fruit of Malpighia emarginata DC) extracts and fractions. Phytother Res 2004 1.32
3 Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008 1.04
4 Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity. In Vivo 2005 1.00
5 Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells. Anticancer Res 2004 0.95
6 Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. Methods Mol Biol 2010 0.94
7 Ultrasound absorption and entropy production in biological tissue: a novel approach to anticancer therapy. Diagn Pathol 2006 0.91
8 Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In Vivo 2010 0.91
9 Biological activity of twenty-three hydantoin derivatives on intrinsic efflux pump system of Salmonella enterica serovar Enteritidis NCTC 13349. In Vivo 2011 0.91
10 Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines. Int J Antimicrob Agents 2011 0.83
11 pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. PLoS One 2009 0.83
12 Synergistic interaction between proton pump inhibitors and resistance modifiers: promoting effects of antibiotics and plasmid curing. In Vivo 2006 0.80
13 Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro. In Vivo 2013 0.80
14 Infectious plasmid resistance and efflux pump mediated resistance. Acta Microbiol Immunol Hung 2004 0.80
15 Inhibition of efflux pumps in methicillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina. Int J Antimicrob Agents 2010 0.79
16 Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells. Anticancer Res 2012 0.79
17 Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells. In Vivo 2006 0.79
18 Physicochemical attack against solid tumors based on the reversal of direction of entropy flow: an attempt to introduce thermodynamics in anticancer therapy. Diagn Pathol 2006 0.79
19 Role of calcium in the efflux system of Escherichia coli. Int J Antimicrob Agents 2011 0.78
20 5-arylidene(thio)hydantoin derivatives as modulators of cancer efflux pump. Acta Pol Pharm 2012 0.78
21 Bacterial models for tumor development. Mini-review. Acta Microbiol Immunol Hung 2004 0.77
22 The mechanism by which the phenothiazine thioridazine contributes to cure problematic drug-resistant forms of pulmonary tuberculosis: recent patents for "new use". Recent Pat Antiinfect Drug Discov 2013 0.76
23 The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus. In Vivo 2012 0.76
24 Structure-antiproliferative activity studies on l-proline- and homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrids and their nickel(ii), palladium(ii) and copper(ii) complexes. Dalton Trans 2016 0.76
25 IL-17E production is elevated in the lungs of Balb/c mice in the later stages of Chlamydia muridarum infection and re-infection. In Vivo 2013 0.75
26 The interaction between resistance modifiers such as pyrido[3,2-g]quinoline, aza-oxafluorene and pregnane derivatives with DNA, plasmid DNA and tRNA. Eur J Med Chem 2005 0.75
27 Effects of a series of dihydroanthracene derivatives on drug efflux in multidrug resistant cancer cells. Eur J Med Chem 2003 0.75
28 Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump. In Vivo 2012 0.75